Recent Quotes

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.

Earnings

Q1 2022		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-13
REV		(EXPECTED)2021-08-13

Q4 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-07-09
REV		(EXPECTED)2021-07-09

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
SNOA	Sonoma Pharmaceuticals	7.78	-0.10	-1.27%		16.2M

Sonoma Pharmaceuticals Frequently Asked Questions

How do I buy Sonoma Pharmaceuticals (SNOA) stock?

You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.

View our list of the best stock brokerages.

Who are Sonoma Pharmaceuticals's (SNOA) competitors?

Other companies in Sonoma Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Titan Pharmaceuticals (NASDAQ:TTNP), BiondVax Pharmaceuticals (NASDAQ:BVXV), Evoke Pharma (NASDAQ:EVOK) and SenesTech (NASDAQ:SNES).

What is the target price for Sonoma Pharmaceuticals (SNOA) stock?

The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to fall to within 12 months (a possible -61.44% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Sonoma Pharmaceuticals (SNOA)?

The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $7.78 last updated Today at 8:00:03 PM.

Does Sonoma Pharmaceuticals (SNOA) pay a dividend?

There are no upcoming dividends for Sonoma Pharmaceuticals.

When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?

Sonoma Pharmaceuticals’s Q1 earnings are confirmed for after-market on August 13, 2021.

Is Sonoma Pharmaceuticals (SNOA) going to split?

There is no upcoming split for Sonoma Pharmaceuticals.

What sector and industry does Sonoma Pharmaceuticals (SNOA) operate in?

Sonoma Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.